Nauticus Robotics, Inc. quarterly report, Q2 FY2023

Nauticus Robotics, Inc. — Q2 2023 Form 10-Q

Reporting period: Three and six months ended June 30, 2023; filed August 14, 2023. Nauticus develops ocean robotics, software and services, including through a Robotics-as-a-Service model. Its core products remained under development, and it reported no product sales in the periods presented.

Financial performance and position

MetricQ2 2023Q2 2022Six months 2023Six months 2022
Revenue$1.13 million$2.99 million$3.95 million$5.23 million
Operating loss$(6.87) million$(2.52) million$(12.69) million$(5.21) million
Net income (loss)$20.67 million$(3.36) million$6.53 million$(6.86) million
Operating cash flowNot separately reported for the quarter$(12.97) million$(9.91) million

Q2 revenue fell 62% year over year; six-month revenue fell 24%. Cost of revenue exceeded revenue in both 2023 periods, indicating negative service gross profit before other operating expenses. Q2 net income was driven principally by a $29.67 million noncash gain from remeasurement of warrant liabilities, not operating profitability. Six-month results included a $27.43 million warrant fair-value gain. The filing reports basic/diluted EPS of $0.52/$0.49 for Q2 and $0.16/$0.16 for the six months.

  • Costs: Q2 general and administrative expense rose 145% to $5.56 million; the six-month amount rose 175% to $10.77 million, primarily reflecting stock compensation, headcount, sales and marketing, professional fees and growth-related costs. Six-month cost of revenue increased 9% to $4.83 million, including contract cost escalation and approximately $0.3 million of retention bonuses. R&D declined 62% for the six months to $0.71 million as the company said hardware and software development had reached technological feasibility and focus shifted toward commercialization.
  • Cash and liquidity: Cash and cash equivalents were $4.35 million at June 30, down from $17.79 million at December 31, 2022. Six-month operating cash use was $12.97 million; capital expenditures were $6.10 million. Current assets were $25.23 million and current liabilities $13.57 million.
  • Debt and liabilities: Secured convertible debentures had $36.53 million principal and $17.80 million net carrying value after unamortized discount; they bear 5% stated interest, mature September 2026 and have an approximately 25.2% effective interest rate. Total liabilities were $38.21 million. Accrued liabilities included $4.32 million associated with registration-rights liquidated damages and interest, and a $1.2 million Texas sales/use tax assessment.
  • Other balance-sheet items: Inventories were $12.54 million, including $11.52 million of work in progress, versus $6.67 million total at year-end. Stockholders’ equity was $10.32 million. Common shares outstanding at June 30 were 47.89 million; the filing reports 49.82 million as of August 11.

Changes, outlook and key risks

  • Management attributed lower revenue mainly to delays in government contract authorizations and supply-chain disruptions. Two customers accounted for 100% of Q2 revenue and 99% of first-half revenue; customer receivables represented 91% of accounts receivable at June 30.
  • Unfulfilled performance obligations were approximately $8.0 million: $2.6 million expected in 2023 and $5.4 million in 2024. These amounts may decline if contracts are modified or terminated.
  • Management said cash, operating revenue, cost controls and potential future financing were expected to fund obligations for at least one year from the report’s issuance. It also stated revenue was insufficient to cover operating expenses, working capital and capital expenditures; there was no committed equity funding, and financing or cost reductions might not be available or sufficient.
  • After quarter-end, the company issued a $5.0 million secured promissory note on July 14, with a 2.5% original issue discount, 15% interest and maturity in September 2026.
  • On June 22, the company agreed to issue 1,890,066 shares to SPA investors to resolve registration-rights claims and revised SPA warrant exercise prices from $20 to a weighted average of $3.28, with tranches from $2.04 to $4.64. Exercises can trigger issuance of additional warrants. The warrant repricing and warrant-liability remeasurement materially affected reported earnings.
  • Disclosure controls were deemed ineffective because of a continuing material weakness involving complex warrant accounting and complex contracts. The weakness had contributed to prior-period restatements, including a restatement related to registration-rights liabilities. Management described remediation efforts but said the weakness was not yet remediated.
  • The company plans to contest the preliminary Texas sales/use tax assessment. It reported no accrual for other routine litigation matters. Management also cited pandemic-related uncertainty, possible supply-chain and staffing disruption, and risks to customer demand and product testing.

Investor verification points:

  • Confirm the company’s cash runway, operating burn and financing needs, including the terms and availability of additional capital after the July note.
  • Assess whether the $8.0 million contracted revenue pipeline converts to recognized revenue on schedule, given authorization and supply delays and customer concentration.
  • Review warrant terms, potential dilution, related-party financing arrangements and the accounting assumptions behind the large noncash warrant gain.
  • Track resolution of the Texas tax assessment and the registration-rights accruals, and reconcile the filing’s MD&A interest-expense discussion with the statement of operations.
  • Monitor remediation of the material weakness and whether subsequent reporting controls operate effectively.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.